Pancreatic Cancer Research

ResearcherUSA Mitchell Cancer InstituteNo recent work listed

Sachin Kumar Deshmukh

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0008-3100-0210; OpenAlex author ID A5103271285. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 3

  1. MYB sustains hypoxic survival of pancreatic cancer cells by facilitating metabolic reprogramming. Co-author DOI 10.15252/embr.202255643↗
  2. ETV4: an emerging target in pancreatic cancer. Co-author DOI 10.18632/oncoscience.471↗
  3. p-21 activated kinase 4 (PAK4) maintains stem cell-like phenotypes in pancreatic cancer cells through activation of STAT3 signaling. Co-author DOI 10.1016/j.canlet.2015.10.028↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Seema Singh · 3 shared papers, 2016–2023 · strength 0.37
  2. Ajay P. Singh · 3 shared papers, 2016–2023 · strength 0.37
  3. Sanjeev K. Srivastava · 2 shared papers, 2016–2023 · strength 0.24
  4. Shafquat Azim · 1 shared paper, 2023 · strength 0.18
  5. Kunwar Somesh Vikramdeo · 1 shared paper, 2023 · strength 0.18
  6. Shashi Anand · 1 shared paper, 2023 · strength 0.18
  7. Mohammad Aslam Khan · 1 shared paper, 2023 · strength 0.18
  8. Arun Bhardwaj · 1 shared paper, 2016 · strength 0.06
  9. Nikhil Tyagi · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.